• Title/Summary/Keyword: 別

Search Result 3, Processing Time 0.016 seconds

Strain Evolution in High-Mn Steel Ellipsoidal Vessel Head during Multi-forming Process: A Finite Element Analysis (다단 성형 공정 시 고-Mn 강의 타원형 용기 헤드에서의 변형률 분포: 유한요소해석)

  • Preetham Alluri;Lalit Kaushik;Shi-Hoon Choi
    • Transactions of Materials Processing
    • /
    • v.32 no.5
    • /
    • pp.268-275
    • /
    • 2023
  • ISO 21029 cryogenic vessel is used to transport cryogenic fluids. High-manganese steel (High-Mn steel) is widely regarded as suitable for use at cryogenic temperatures. The conventional way of manufacturing an ellipsoidal vessel head involves incremental stretching, followed by a spinning process. In this study, an alternative method for forming an ellipsoidal vessel head was proposed. Finite element analysis (FEA) was used to theoretically examine the strain evolution during a multi-stage forming process, which involved progressive stretching, deep drawing, and spinning of High-Mn steel. The distribution of effective strain and strain components were analyzed at different regions of the formed part. The FEA results revealed that only normal strains were evident in the dished region of the vessel head due to the stretching process. However, the flange region experienced complex strain evolution during the subsequent deep drawing and spinning process.

Genetic analysis of the postsynaptic transmembrane X-linked neuroligin 3 gene in autism

  • Hegde, Rajat;Hegde, Smita;Kulkarni, Suyamindra S.;Pandurangi, Aditya;Gai, Pramod B.;Das, Kusal K.
    • Genomics & Informatics
    • /
    • v.19 no.4
    • /
    • pp.44.1-44.9
    • /
    • 2021
  • Autism is a complex neurodevelopmental disorder, the prevalence of which has increased drastically in India in recent years. Neuroligin is a type I transmembrane protein that plays a crucial role in synaptogenesis. Alterations in synaptic genes are most commonly implicated in autism and other cognitive disorders. The present study investigated the neuroligin 3 gene in the Indian autistic population by sequencing and in silico pathogenicity prediction of molecular changes. In total, 108 clinically described individuals with autism were included from the North Karnataka region of India, along with 150 age-, sex-, and ethnicity-matched healthy controls. Genomic DNA was extracted from peripheral blood, and exonic regions were sequenced. The functional and structural effects of variants of the neuroligin 3 protein were predicted. One coding sequence variant (a missense variant) and four non-coding variants (two 5'-untranslated region [UTR] variants and two 3'-UTR variants) were recorded. The novel missense variant was found in 25% of the autistic population. The C/C genotype of c.551T>C was significantly more common in autistic children than in controls (p = 0.001), and a significantly increased risk of autism (24.7-fold) was associated with this genotype (p = 0.001). The missense variant showed pathogenic effects and high evolutionary conservation over the functions of the neuroligin 3 protein. In the present study, we reported a novel missense variant, V184A, which causes abnormal neuroligin 3 and was found with high frequency in the Indian autistic population. Therefore, neuroligin is a candidate gene for future molecular investigations and functional analysis in the Indian autistic population.

Clinical Research Trends of Gut Microbiome for Respiratory Diseases (호흡기질환에 대한 장내 미생물의 임상 연구 동향)

  • Lee, Su Won;Choi, Jin Kwan;Yang, Won Kyung;Kim, Seung Hyung;Lyu, Yee Ran;Park, Yang Chun
    • The Journal of Korean Medicine
    • /
    • v.42 no.3
    • /
    • pp.119-138
    • /
    • 2021
  • Objectives: This study aimed to review the clinical research of the gut microbiome for respiratory diseases to assist the design of trials for respiratory diseases by regulating the gut microbiome with herbal medicine later. Methods: We searched three international databases (PubMed, CENTRAL and EMBASE) to investigate randomized controlled trials (RCTs) of the gut microbiome for respiratory diseases. The selected trials were analyzed by study design, subject diseases, inclusion/exclusion criteria, sample size, study period, intervention group, control group, outcome measures, and study results. Results: A total of 25 studies were included and published from 1994 to 2021 mostly in Europe and Asia. Subject diseases were many in the order of respiratory tract infection, cystic fibrosis, allergy, and so on. As outcome measures, the gut microbiome in a fecal sample was analyzed by 16S rRNA sequencing analysis method, and symptom assessment tools related each disease were used. Major intervention drugs were probiotics and the results were mostly improved in the composition and diversity of the gut microbiome. Conclusion: Clinical studies of the gut microbiome for respiratory diseases have confirmed various effects and this review provides basic data for a well-designed clinical study for respiratory diseases by regulating the gut microbiome with herbal medicine.